68860-39-9

Basic information

• Product Name: Benzaldehyde, 5-bromo-2-(methoxymethoxy)-
• CAS NO: 68860-39-9
• Molecular Formula: C9H9BrO3
• Molecular Weight: 245.073
• Mol File: 68860-39-9.mol
• Article Data: 13

Chemical Properties

• CAS DataBase Reference: Benzaldehyde, 5-bromo-2-(methoxymethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzaldehyde, 5-bromo-2-(methoxymethoxy)-(68860-39-9)
• EPA Substance Registry System: Benzaldehyde, 5-bromo-2-(methoxymethoxy)-(68860-39-9)

Safety Data

• Hazardous Substances Data: 68860-39-9(Hazardous Substances Data)

Upstream product

• 90-02-8 salicylaldehyde 
• 124-41-4 sodium methylate 
• 1761-61-1 5-bromosalicyclaldehyde 
• 107-30-2 chloromethyl methyl ether 

Downstream Products

• 153240-85-8 2-(benzyloxy)-4-bromophenol 
• 944333-95-3 4-bromo-2-cyclobutoxy-1-methoxymethoxybenzene 
• 944334-02-5 4-bromo-2-cyclobutoxy-1-methoxybenzene 
• 944333-96-4 4-bromo-2-cyclobutoxyphenol 

Relevant articles and documents

Facile Synthesis of 2-Fluorobenzofurans: 5-endo-trig Cyclization of β,β-Difluoro-o-hydroxystyrenes

Efficient synthetic methods were established for obtaining 2-fluorobenzofurans involving various substituents. Upon being treated with 1,8-diazabicyclo[5.4.0]undec-7-ene under microwave irradiation, the α-unsubstituted β,β-difluoro-o-hydroxystyrenes under

PD-1/PD-L1 small-molecule inhibitor and preparation method and application thereof

The invention discloses a PD-1/PD-L1 small-molecule inhibitor and a preparation method and application thereof. Specifically, the invention discloses a compound with the structure shown in the formulaL, a stereoisomer or a tautomer thereof, or pharmaceutically acceptable salts or hydrates or solvates thereof, and please see the specification for specific definitions. The compound has excellent effects for restraining PD-1/PD-L1. Please see the specification for the formula.

PIPERIDINE-DIONE DERIVATIVES

The invention provides novel compounds having the general formula (I) and tautomers and pharmaceutically acceptable salts thereof, wherein A1, A2, A3, A4, R1, R4, R5, R6, R7 and R8 are as defined herein, compositions including the compounds and methods of using the compounds.